Historically, autism has been recognized for its heterogeneity, with individuals displaying a broad spectrum of behavioral symptoms and neurodevelopmental trajectories. Yet the precise neurobiological underpinnings of these variations have remained elusive. This study transcends behavioral categorizations by employing functional magnetic resonance imaging (fMRI) to delineate two reproducible connectivity-based phenotypes: one exhibiting pronounced “hyperconnectivity,” marked by elevated communication between brain regions, and the other demonstrating “hypoconnectivity,” characterized by diminished interaction. Each subtype corresponds to separate, identifiable molecular pathways, providing a biological framework for understanding autism’s complexity.

Central to this advance is the innovative cross-species methodology adopted by the research team. Leveraging 20 distinct genetically engineered mouse models of autism, the investigators undertook a comprehensive analysis of functional connectivity patterns and correlated these with gene expression and biochemical alterations. These animal data acted as a molecular “Rosetta Stone,” illuminating how synaptic and immune-related dysfunctions translate into specific brain network disruptions observable via fMRI. Subsequently, the team translated these murine connectivity signatures into the human context, analyzing resting-state fMRI datasets from 940 individuals diagnosed with autism alongside over 1,000 neurotypical controls.

The resultant findings were striking. Approximately one quarter of the human autism cohort could be stratified into two biologically anchored subgroups mirroring the mouse model connectivity profiles. The hypoconnectivity subtype linked strongly with synaptic gene expression profiles, implicating deficits in neuronal communication and synaptic plasticity pathways. Conversely, the hyperconnectivity group correlated with immune-related gene enrichment, suggesting neuroimmune interactions and possible neuroinflammatory processes as central drivers. Notably, these subtypes were robustly reproducible across independent datasets collated by the Autism Brain Imaging Data Exchange (ABIDE) and the Child Mind Institute, underscoring the validity of the brain connectivity classifications.

This refined understanding reframes autism not as a single monolithic disorder but as a constellation of pathophysiological processes each associated with distinct neural circuit dysfunctions. Dr. Gozzi emphasizes that this distinction has eluded the field for decades due to the lack of integrated multimodal analysis linking molecular biology directly to brain imaging phenotypes. By bridging genetic, cellular, and systems neuroscience approaches, the current study paves the way for biomarker-driven stratification, facilitating tailored therapeutic strategies that target subtype-specific mechanisms.

From a clinical perspective, the identified subtypes exhibit subtle but meaningful divergences in functional brain organization and autism severity scores. Individuals within the hyperconnected subtype tended to score higher on standardized autism severity assessments, potentially reflecting differences in symptom profiles that are not fully captured by behavioral metrics alone. This accentuates the limitations inherent in current diagnostic frameworks and underscores the potential of neurobiological markers to enhance diagnostic precision and outcome prediction.

The methodology driving these discoveries combined state-of-the-art neuroimaging techniques with transcriptomic analyses, enabling a multilevel, integrative view of autism neurobiology. Functional neuroimaging data were meticulously analyzed to derive connectivity matrices reflecting the strength and patterning of interregional brain communication networks. Parallel gene expression analyses, derived from both mouse tissue and human brain samples, elucidated the molecular pathways associated with distinct connectivity signatures. This cross-disciplinary nexus of computational neuroscience, genetics, and immunology represents a powerful paradigm for decoding the complexities of neurodevelopmental disorders.

Nevertheless, the researchers caution that while these two subtypes represent dominant patterns within the examined cohorts, the autism spectrum likely encompasses additional variants awaiting discovery. The study calls for ongoing efforts to aggregate larger, more diverse datasets and apply refined analytic models to capture the full gamut of autism’s neural heterogeneity. Expanding these efforts could ultimately yield a comprehensive taxonomy grounded firmly in biology, accelerating the development of more effective, personalized interventions.

Funding for this research was provided by a consortium of prestigious institutions, including the European Research Council, the Simons Foundation Autism Research Initiative, the Brain and Behavior Foundation, Fondazione Telethon, and the US National Institute of Mental Health. The successful collaboration between high-caliber institutions across continents epitomizes the global commitment to unraveling autism’s mysteries through cutting-edge science.

The implications of this study reverberate well beyond the immediate autism research community. By elucidating how distinct genetic and immune pathways sculpt brain connectivity patterns, it contributes to an enriched understanding of neurodevelopmental dynamics more broadly. Moreover, the innovative cross-species translational framework employed sets a new standard for the integration of animal modeling and human neuroimaging, a strategy that could be applied to a wide spectrum of neurological and psychiatric disorders exhibiting complex etiologies.

In conclusion, this landmark investigation delineates discrete neurobiological subtypes of autism based on brain network connectivity and their molecular correlates. The clear identification of hypoconnectivity linked to synaptic dysfunction and hyperconnectivity tied to immune mechanisms provides a crucial conceptual leap towards personalized autism care. As neuroimaging technology and multi-omics approaches continue to evolve, such insights will be pivotal in transforming diagnosis, prognostication, and therapeutic targeting, ultimately enhancing quality of life for individuals on the autism spectrum and their families.

Subject of Research: People

Article Title: Autism subtypes identified using cross-species functional connectivity analyses

News Publication Date: 29-May-2026

Web References:
https://doi.org/10.1038/s41593-026-02287-z
Italian Institute of Technology (IIT)
Child Mind Institute

References:
Gozzi, A., Di Martino, A., et al. (2026). Autism subtypes identified using cross-species functional connectivity analyses. Nature Neuroscience. DOI: 10.1038/s41593-026-02287-z

Image Credits: IIT-Istituto Italiano di Tecnologia

Keywords: Autism, Developmental disabilities, Neuroscience, Functional neuroimaging, Developmental neuroscience, Molecular biology, Genetics

For decades, understanding the heterogeneity within autism has challenged scientists and clinicians alike, as the spectrum encompasses a wide range of neurodevelopmental manifestations with variable severity and symptom profiles. By leveraging high-resolution brain imaging and cross-species modeling, the team, led by Dr. Alessandro Gozzi of IIT and Dr. Adriana Di Martino of the Child Mind Institute, has successfully identified two robust autism subtypes. These are characterized by either hyperconnectivity, where excessive communication occurs between distinct brain regions, or hypoconnectivity, marked by diminished interregional signaling. Each subtype correlates to distinct molecular pathways, illuminating the complex biology that shapes autism phenotypes.

Central to this study was the integration of human neuroimaging data from over 940 individuals diagnosed with autism, supplemented by more than 1,000 neurotypical controls, with comprehensive analyses of 20 genetically distinct mouse models of ASD. This cross-species approach allowed the researchers to decode the functional connectivity signatures observable via fMRI and trace them back to fundamental molecular mechanisms. Intriguingly, the hypoconnectivity subtype was predominantly linked to disruptions in synaptic pathways—reflecting alterations in neuronal communication at the cellular level—while the hyperconnectivity subtype was associated with immune-related biological processes, suggesting neuroimmune interactions as a key driver.

Prior to this work, characterizing autism subtypes relied heavily on behavioral phenotyping, which often failed to capture the biological diversity driving these conditions. The current research transcends this limitation by pinpointing reproducible connectivity patterns connected to specific genetic and immune signatures. This mechanistic insight was achieved by correlating gene expression profiles with fMRI connectivity anomalies in mice, then identifying analogous patterns in human participants. Such a translational methodology offers a “biological Rosetta Stone,” as described by Dr. Di Martino, bridging experimental neurobiology and clinical neuroscience.

Further validation came from the reproducibility of these connectivity subtypes across multiple independent datasets sourced from the Autism Brain Imaging Data Exchange (ABIDE), a robust consortium that aggregates brain scans from research centers worldwide. The consistent detection of hypo- and hyperconnectivity patterns across these diverse cohorts underscores the biological validity of these subtypes and their relevance to broader autism populations. It also highlights the promise of resting-state functional connectivity as a biomarker for dissecting the autism spectrum.

Significantly, the research elucidates the functional brain architecture that distinguishes these subtypes. The hypoconnected subgroup, enriched for synaptic gene expression, exhibits attenuated communication between critical neural circuits, which may underlie some of the cognitive and social difficulties observed. Conversely, the hyperconnected cohort, characterized by heightened immune gene activity, shows amplified neural connectivity that may correspond with increased autism severity as measured by standardized clinical scales. This delineation suggests that immune dysregulation is not merely a bystander but an active participant in shaping neural networks in ASD.

Importantly, the findings articulate that behavioral assessments currently employed in clinical settings inadequately capture the nuanced neurobiological differences manifested in these subtypes. Brain-based biological markers, as evidenced here, provide an orthogonal avenue to more accurately classify autism heterogeneity, which may lead to more targeted interventions. While the two identified subtypes encapsulate approximately 25% of the studied autistic population, the researchers caution that the full spectrum likely harbors additional subtypes awaiting discovery as analytical tools and datasets expand.

Technically, the investigators employed advanced fMRI analytic pipelines capable of capturing whole-brain resting-state connectivity, integrated with transcriptomic data to annotate each brain region’s gene expression profile. Mouse models carrying various autism-associated genetic modifications allowed the dissection of causative pathways, identifying synaptic and immune molecular cascades underlying connectivity abnormalities. This integrative approach represents a paradigm shift in neurodevelopmental research, moving beyond symptom-based classifications toward mechanistic understanding.

This pioneering work has been made possible by extensive collaboration and funding from entities such as the Simons Foundation Autism Research Initiative, the European Research Council via projects DISCONN and BRAINAMICS, the Brain and Behavior Foundation, Fondazione Telethon, and the US National Institute of Mental Health. The alignment of cutting-edge neuroimaging, molecular genetics, and computational neuroscience exemplifies the future of precision psychiatry, where patient stratification is informed by biology rather than behavioral observation alone.

In sum, this study marks a critical advancement in autism research by establishing direct links between brain connectivity subtypes and their molecular underpinnings. By systematically mapping neural circuits to genetic and immune system pathways across species, the researchers offer unprecedented insight into the biological architecture of autism. These findings are set to revolutionize diagnostic frameworks and therapeutic approaches, accelerating the development of personalized medicine in ASD and similar neurodevelopmental conditions.

The full research article, titled “Autism subtypes identified using cross-species functional connectivity analyses,” is accessible through Nature Neuroscience and offers comprehensive details on methodology, data analysis, and implications for future research. This research not only broadens our comprehension of autism’s biological diversity but also opens new avenues for targeted treatment, marking a hopeful trajectory for millions affected globally.

Subject of Research: People
Article Title: Autism subtypes identified using cross-species functional connectivity analyses
News Publication Date: May 29, 2026
Web References: https://doi.org/10.1038/s41593-026-02287-z
References: Published in Nature Neuroscience
Keywords: Autism, Functional magnetic resonance imaging, Neuroimaging, Developmental neuroscience, Neural pathways, Developmental biology, Biological models